Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 29;44(10):2397-2402.
doi: 10.2337/dc20-2882. Online ahead of print.

Eye Outcomes in Veteran Affairs Diabetes Trial (VADT) After 17 Years

Nasrin Azad  1   2 , Lily Agrawal  3   2 , Gideon Bahn  2 , Nicholas V Emanuele  3   2 , Peter D Reaven  4 , Rodney Hayward  5 , Domenic Reda; VADT Study Group
Affiliations

Eye Outcomes in Veteran Affairs Diabetes Trial (VADT) After 17 Years

Nasrin Azad et al. Diabetes Care. .

Abstract

Objective: The objective of this study was to assess the long-term role of intensive glycemic control (INT) compared with standard glycemic control in accumulated eye procedures in patients with advanced diabetes.

Research design and methods: We compared the effect of treatment assignment on the accumulated number of eye procedures during the intervention period of the Veteran Affairs Diabetes Trial (VADT) (2000-2008) (median follow-up 5.6 years), the interim VADT follow-up study (2000-2013), and the full 17 years of VADT follow-up (2000-2017). We further analyzed data using various cardiovascular markers in two models. Model I included total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, systolic and diastolic blood pressure, and BMI. Model II included these covariates plus age and diabetic retinopathy (DR) severity score at baseline of the original trial.

Results: The final analysis of the data showed a mild but nonsignificant increase in number of procedures and in retinal or retinal plus cataract surgery during the three periods of the study.

Conclusions: We found no significant benefit of INT during the original trial period in eye-related procedures, such as various procedures for DR, or during the 17 years of follow-up in cataract surgery. However, after adjusting data for some known vascular markers, the increase in the number of eye procedures with INT becomes more prevalent. This finding indicates that INT might not have a protective role in events requiring surgery in individuals with advanced diabetes.

PubMed Disclaimer

References

    1. UK Prospective Diabetes Study (UKPDS) Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–853 - PubMed
    1. Chew EY, Ambrosius WT, Davis MD, et al.; ACCORD Study Group; ACCORD Eye Study Group . Effects of medical therapies on retinopathy progression in type 2 diabetes [published corrections appear in N Engl J Med 2011;364:190 and N Engl J Med 2012;367:2458]. N Engl J Med 2010;363:233–244 - PMC - PubMed
    1. Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group . Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560–2572 - PubMed
    1. Nathan DM, Genuth S, Lachin J, et al.; Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986 - PubMed
    1. Azad N, Agrawal L, Emanuele NV, et al.; VADT Study Group . Association of blood glucose control and pancreatic reserve with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT). Diabetologia 2014;57:1124–1131 - PubMed